Mousavi M - Search Results

1

Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.

Nordberg A, Darreh-Shori T, Peskind E, Soininen H, Mousavi M, Eagle G, Lane R. Nordberg A, et al. Among authors: mousavi m. Curr Alzheimer Res. 2009 Feb;6(1):4-14. doi: 10.2174/156720509787313961. Curr Alzheimer Res. 2009. PMID: 19199870 Free PMC article. Clinical Trial.

2

Apolipoprotein ε4 modulates phenotype of butyrylcholinesterase in CSF of patients with Alzheimer's disease.

Darreh-Shori T, Siawesh M, Mousavi M, Andreasen N, Nordberg A. Darreh-Shori T, et al. Among authors: mousavi m. J Alzheimers Dis. 2012;28(2):443-58. doi: 10.3233/JAD-2011-111088. J Alzheimers Dis. 2012. PMID: 22012848

3

Expression of the alpha7, alpha4 and alpha3 nicotinic receptor subtype in the brain and adrenal medulla of transgenic mice carrying genes coding for human AChE and beta-amyloid.

Mousavi M, Nordberg A. Mousavi M, et al. Int J Dev Neurosci. 2006 Jun;24(4):269-73. doi: 10.1016/j.ijdevneu.2006.02.002. Epub 2006 Mar 30. Int J Dev Neurosci. 2006. PMID: 16574369

4

Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients.

Hellström-Lindahl E, Mousavi M, Ravid R, Nordberg A. Hellström-Lindahl E, et al. Among authors: mousavi m. Neurobiol Dis. 2004 Mar;15(2):351-60. doi: 10.1016/j.nbd.2003.11.024. Neurobiol Dis. 2004. PMID: 15006705

5

Selective changes in expression of different nicotinic receptor subtypes in brain and adrenal glands of mice carrying human mutated gene for APP or over-expressing human acetylcholinestrase.

Mousavi M, Bednar I, Nordberg A. Mousavi M, et al. Int J Dev Neurosci. 2004 Nov;22(7):545-9. doi: 10.1016/j.ijdevneu.2004.07.005. Int J Dev Neurosci. 2004. PMID: 15465284

6

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.

Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A. Kadir A, et al. Among authors: mousavi m. Brain. 2011 Jan;134(Pt 1):301-17. doi: 10.1093/brain/awq349. Epub 2010 Dec 13. Brain. 2011. PMID: 21149866 Free PMC article.

7

Chronic nicotine treatment reduces beta-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw).

Nordberg A, Hellström-Lindahl E, Lee M, Johnson M, Mousavi M, Hall R, Perry E, Bednar I, Court J. Nordberg A, et al. Among authors: mousavi m. J Neurochem. 2002 May;81(3):655-8. doi: 10.1046/j.1471-4159.2002.00874.x. J Neurochem. 2002. PMID: 12065674 Free article.

8

Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease.

Mousavi M, Hellström-Lindahl E, Guan ZZ, Shan KR, Ravid R, Nordberg A. Mousavi M, et al. Neuroscience. 2003;122(2):515-20. doi: 10.1016/s0306-4522(03)00460-3. Neuroscience. 2003. PMID: 14614915

9

Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain.

Hellström-Lindahl E, Mousavi M, Zhang X, Ravid R, Nordberg A. Hellström-Lindahl E, et al. Among authors: mousavi m. Brain Res Mol Brain Res. 1999 Mar 20;66(1-2):94-103. doi: 10.1016/s0169-328x(99)00030-3. Brain Res Mol Brain Res. 1999. PMID: 10095081

10

Selective changes in the levels of nicotinic acetylcholine receptor protein and of corresponding mRNA species in the brains of patients with Parkinson's disease.

Guan ZZ, Nordberg A, Mousavi M, Rinne JO, Hellström-Lindahl E. Guan ZZ, et al. Among authors: mousavi m. Brain Res. 2002 Nov 29;956(2):358-66. doi: 10.1016/s0006-8993(02)03571-0. Brain Res. 2002. PMID: 12445706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

681 results

Search Page

Filters